Literature DB >> 8880527

Direct activity of recombinant human lactoferrin against Helicobacter pylori.

S Miehlke1, R Reddy, M S Osato, P P Ward, O M Conneely, D Y Graham.   

Abstract

We report the activity of recombinant human lactoferrin against Helicobacter pylori. Lactoferrin exerted a time- and dose-dependent action against 8 of the 13 clinical isolates of H. pylori tested in vitro. These results highlight a potential therapeutic use for lactoferrin against H.pylori infection.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8880527      PMCID： PMC229326          DOI： 10.1128/jcm.34.10.2593-2594.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  8 in total

1.  Identification of the bactericidal domain of lactoferrin.

Authors:  W Bellamy; M Takase; K Yamauchi; H Wakabayashi; K Kawase; M Tomita
Journal:  Biochim Biophys Acta       Date:  1992-05-22

2.  A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic.

Authors:  P P Ward; C S Piddington; G A Cunningham; X Zhou; R D Wyatt; O M Conneely
Journal:  Biotechnology (N Y)       Date:  1995-05

3.  Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin.

Authors:  R T Ellison; T J Giehl; F M LaForce
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

Review 4.  Role of iron in bacterial infection.

Authors:  J J Bullen; H J Rogers; E Griffiths
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

5.  Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia.

Authors:  L Maiuri; M Rossi; V Raia; F Paparo; V Garipoli; S Auricchio
Journal:  Gastroenterology       Date:  1993-09       Impact factor: 22.682

Review 6.  The biological significance of lactoferrin.

Authors:  B Reiter
Journal:  Int J Tissue React       Date:  1983

7.  Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms.

Authors:  R R Arnold; M Brewer; J J Gauthier
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

8.  Lactoferrin, an iron-binding protein in neutrophilic leukocytes.

Authors:  P L Masson; J F Heremans; E Schonne
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307
  8 in total
  8 in total

1.  Does bovine lactoferrin inhibit Helicobacter pylori?

Authors:  C Joshi; N Wattanapenpaiboon; M L Wahlqvist; P Midolo; J Lambert
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

2.  Human lactoferrin increases Helicobacter pylori internalisation into AGS cells.

Authors:  Dorien S Coray; Jack A Heinemann; Peter C Tyrer; Jacqueline I Keenan
Journal:  World J Microbiol Biotechnol       Date:  2012-02-07       Impact factor: 3.312

3.  Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur.

Authors:  Florian D Ernst; Georg Homuth; Jeroen Stoof; Ulrike Mäder; Barbara Waidner; Ernst J Kuipers; Manfred Kist; Johannes G Kusters; Stefan Bereswill; Arnoud H M van Vliet
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

Review 4.  Dietary amelioration of Helicobacter infection.

Authors:  Jed W Fahey; Katherine K Stephenson; Alison J Wallace
Journal:  Nutr Res       Date:  2015-03-06       Impact factor: 3.315

5.  Antibiotic properties of bovine lactoferrin on Helicobacter pylori.

Authors:  E J Dial; L R Hall; H Serna; J J Romero; J G Fox; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

6.  Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.

Authors:  Yuping Yuan; Qinyi Wu; Guoxiang Cheng; Xuefang Liu; Siguo Liu; Juan Luo; Aimin Zhang; Li Bian; Jianquan Chen; Jiajun Lv; Xiangqian Dong; Gang Yang; Yunzhen Zhu; Lanqing Ma
Journal:  Int J Mol Med       Date:  2015-06-17       Impact factor: 4.101

7.  Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection.

Authors:  Louise Sjökvist Ottsjö; Carl-Fredrik Flach; Staffan Nilsson; Rene de Waal Malefyt; Anna K Walduck; Sukanya Raghavan
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

8.  Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.

Authors:  Antonio Francesco Ciccaglione; Mara Di Giulio; Silvia Di Lodovico; Emanuela Di Campli; Luigina Cellini; Leonardo Marzio
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.790
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.